Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

HJ Whitaker, RSM Tsang, R Byford, NJ Andrews… - Journal of Infection, 2022 - Elsevier
Background COVID-19 vaccines approved in the UK are highly effective in general
population cohorts, however, data on effectiveness amongst individuals with clinical …

[HTML][HTML] COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care …

HJ Whitaker, RSM Tsang, R Byford, C Aspden… - Journal of Infection, 2023 - Elsevier
Background COVID-19 vaccines have been shown to be highly effective against
hospitalisation and death following COVID-19 infection. COVID-19 vaccine effectiveness …

Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from …

BD Nicholson, JM Ordóñez-Mena, S Lay-Flurrie… - British journal of …, 2022 - nature.com
Background It remains unclear to what extent reductions in urgent referrals for suspected
cancer during the COVID-19 pandemic were the result of fewer patients attending primary …

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self …

RSM Tsang, M Joy, R Byford, C Robertson… - …, 2023 - eurosurveillance.org
Background Post-authorisation vaccine safety surveillance is well established for reporting
common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 …

[HTML][HTML] Exploratory literature review of the role of national public health institutes in COVID-19 response

A Zuber, Y Sebeh, D Jarvis, S Bratton - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
To help explain the diversity of COVID-19 outcomes by country, research teams worldwide
are studying national government response efforts. However, these attempts have not …

Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the …

M Joy, U Agrawal, X Fan, C Robertson… - The Lancet Regional …, 2023 - thelancet.com
Background Thrombosis associated with thrombocytopenia was a matter of concern post
first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is …

[HTML][HTML] Postpandemic sentinel surveillance of respiratory diseases in the context of the world health organization mosaic framework: Protocol for a development and …

X Gu, C Watson, U Agrawal, H Whitaker… - JMIR Public Health and …, 2024 - jmir.org
Background: Prepandemic sentinel surveillance focused on improved management of
winter pressures, with influenza-like illness (ILI) being the key clinical indicator. The World …

[HTML][HTML] A Profile of Influenza Vaccine Coverage for 2019-2020: Database Study of the English Primary Care Sentinel Cohort

U Hoang, G Delanerolle, X Fan… - JMIR public health …, 2024 - publichealth.jmir.org
Background: Innovation in seasonal influenza vaccine development has resulted in a wider
range of formulations becoming available. Understanding vaccine coverage across …

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network

H Whitaker, RSM Tsang, E Button, N Andrews… - Journal of Infection, 2022 - Elsevier
Objectives To monitor changes in seroprevalence of SARS-CoV-2 antibodies in populations
over time and between different demographic groups. Methods A subset of practices in the …

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study

S de Lusignan, M Joy, J Sherlock, M Tripathy… - BJGP open, 2021 - bjgpopen.org
Background The Platform Randomised trial of INterventions against COVID-19 In older
peoPLE (PRINCIPLE) has provided in-pandemic evidence that azithromycin and …